Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Serum levels of S100B and NSE proteins in Alzheimer's disease patients.

Chaves ML, Camozzato AL, Ferreira ED, Piazenski I, Kochhann R, Dall'Igna O, Mazzini GS, Souza DO, Portela LV.

J Neuroinflammation. 2010 Jan 27;7:6. doi: 10.1186/1742-2094-7-6.

2.

Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.

Zhou J, Lei L, Shi Y, Wang J, Jiang H, Shen L, Tang B.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jun;36(6):504-10. doi: 10.3969/j.issn.1672-7347.2011.06.006.

3.

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.

Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM.

Neurology. 2004 Apr 27;62(8):1303-10.

PMID:
15111666
4.

Elevated serum S100B protein and neuron-specific enolase levels in carbon monoxide poisoning.

Yardan T, Cevik Y, Donderici O, Kavalci C, Yilmaz FM, Yilmaz G, Vural K, Yuzbasioglu Y, Gunaydin YK, Sezer AA.

Am J Emerg Med. 2009 Sep;27(7):838-42. doi: 10.1016/j.ajem.2008.04.016.

PMID:
19683113
5.

Comparative study on carotid revascularization (endarterectomy vs stenting) using markers of cellular brain injury, neuropsychometric tests, and diffusion-weighted magnetic resonance imaging.

Capoccia L, Speziale F, Gazzetti M, Mariani P, Rizzo A, Mansour W, Sbarigia E, Fiorani P.

J Vasc Surg. 2010 Mar;51(3):584-91, 591.e1-3; discussion 592. doi: 10.1016/j.jvs.2009.10.079. Epub 2010 Jan 4.

6.

Brain injury markers (S100B and NSE) in chronic cocaine dependents.

Kessler FH, Woody G, Portela LV, Tort AB, De Boni R, Peuker AC, Genro V, von Diemen L, de Souza DO, Pechansky F.

Rev Bras Psiquiatr. 2007 Jun;29(2):134-9.

PMID:
17650535
7.

Markers of cerebral damage during delirium in elderly patients with hip fracture.

van Munster BC, Korse CM, de Rooij SE, Bonfrer JM, Zwinderman AH, Korevaar JC.

BMC Neurol. 2009 May 27;9:21. doi: 10.1186/1471-2377-9-21.

8.

S100B and NSE serum levels in patients with Parkinson's disease.

Schaf DV, Tort AB, Fricke D, Schestatsky P, Portela LV, Souza DO, Rieder CR.

Parkinsonism Relat Disord. 2005 Jan;11(1):39-43.

PMID:
15619461
9.

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

Geyer C, Ulrich A, Gräfe G, Stach B, Till H.

J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.

PMID:
19795965
10.

S100B and NSE serum levels in obstructive sleep apnea syndrome.

Braga CW, Martinez D, Wofchuk S, Portela LV, Souza DO.

Sleep Med. 2006 Aug;7(5):431-5. Epub 2006 Jun 5.

PMID:
16750933
11.

Significance of serial S100b and NSE serum measurements in surgically treated patients with spondylotic cervical myelopathy.

Marquardt G, Setzer M, Szelenyi A, Seifert V, Gerlach R.

Acta Neurochir (Wien). 2009 Nov;151(11):1439-43. doi: 10.1007/s00701-009-0408-0. Epub 2009 Jun 5.

PMID:
19499171
12.

Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs.

Potapov EV, Loebe M, Abdul-Khaliq H, Koster A, Stein J, Sodian R, Kopitz M, Hausmann H, Noon GP, DeBakey ME, Hetzer R.

J Heart Lung Transplant. 2001 Dec;20(12):1310-6.

PMID:
11744415
13.

Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis.

Hamed SA, Selim ZI, Elattar AM, Elserogy YM, Ahmed EA, Mohamed HO.

Clin Rheumatol. 2012 Jan;31(1):123-32. doi: 10.1007/s10067-011-1795-1. Epub 2011 Jun 22.

PMID:
21695659
14.

Serum concentrations of s100b and NSE in migraine.

Teepker M, Munk K, Mylius V, Haag A, Möller JC, Oertel WH, Schepelmann K.

Headache. 2009 Feb;49(2):245-52. doi: 10.1111/j.1526-4610.2008.01228.x. Epub 2009 Sep 9.

PMID:
18783450
16.

[Clinical values of detection of serum levels of S100B and NSE in diagnosis of brain injuries at early period after cardiopulmonary bypass].

Gu XH, Zhang G, Zhang XQ, Song Y, Wang T, Li SX.

Zhonghua Yi Xue Za Zhi. 2007 Apr 10;87(14):975-7. Chinese.

PMID:
17650423
17.

Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients.

González-García S, González-Quevedo A, Fernández-Concepción O, Peña-Sánchez M, Menéndez-Saínz C, Hernández-Díaz Z, Arteche-Prior M, Pando-Cabrera A, Fernández-Novales C.

Clin Biochem. 2012 Nov;45(16-17):1302-7. doi: 10.1016/j.clinbiochem.2012.07.094. Epub 2012 Jul 20.

PMID:
22820433
18.

The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.

Moritz S, Warnat J, Bele S, Graf BM, Woertgen C.

J Neurosurg Anesthesiol. 2010 Jan;22(1):21-31. doi: 10.1097/ANA.0b013e3181bdf50d.

PMID:
20027011
19.

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

Peskind ER, Griffin WS, Akama KT, Raskind MA, Van Eldik LJ.

Neurochem Int. 2001 Nov-Dec;39(5-6):409-13.

PMID:
11578776
20.

Elevated S100B and neuron specific enolase levels in patients with migraine-without aura: evidence for neurodegeneration?

Yilmaz N, Karaali K, Ozdem S, Turkay M, Unal A, Dora B.

Cell Mol Neurobiol. 2011 May;31(4):579-85. doi: 10.1007/s10571-011-9651-z. Epub 2011 Feb 4.

PMID:
21293918

Supplemental Content

Support Center